Results 11 to 20 of about 1,740,794 (265)

Incidence and overall survival of malignant ameloblastoma.

PLoS ONE, 2015
BackgroundMalignant ameloblastoma, comprising metastasizing ameloblastoma and ameloblastic carcinoma, represents 1.6-2.2% of all odontogenic tumors. Due to its rare nature, malignant ameloblastoma has only been reported in the literature in small case ...
Alexandra Rizzitelli, Nicolas R Smoll, Michael P Chae, Warren M Rozen, David J Hunter-Smith, David J Hunter-Smith   +5 more
doaj   +6 more sources

Diet and overall survival in elderly people [PDF]

BMJ, 1995
Abstract Objective : To assess the influence of a specific dietary pattern on overall survival. Design : Cohort study.
TRICHOPOULOU, A, KOURISBLAZOS, A, WAHLQVIST, ML, GNARDELLIS, C, LAGIOU, P, POLYCHRONOPOULOS, E, VASSILAKOU, T, LIPWORTH, L, TRICHOPOULOS, D   +8 more
openaire   +3 more sources

Apalutamide and Overall Survival in Prostate Cancer

European Urology, 2021
The phase 3 SPARTAN study evaluated apalutamide versus placebo in patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) and prostate-specific antigen doubling time of ≤10 mo. At primary analysis, apalutamide improved median metastasis-free survival (MFS) by 2 yr and overall survival (OS) data were immature.We report the prespecified
Smith, Matthew R., Saad, Fred, Chowdhury, Simon, Oudard, Stéphane, Hadaschik, Boris, Graff, Julie N., Olmos, David, Mainwaring, Paul N., Lee, Ji Youl, Uemura, Hiroji, De Porre, Peter, Smith, Andressa A., Brookman-May, Sabine D., Li, Susan, Zhang, Ke, Rooney, Brendan, Lopez-Gitlitz, Angela, Small, Eric J.   +17 more
openaire   +4 more sources

Osteosarcoma of the Pelvis: Clinical Presentation and Overall Survival [PDF]

Sarcoma, 2021
Introduction. Osteosarcoma is the most common sarcoma of bone. Pelvic osteosarcoma presents a significant therapeutic challenge due to potential late symptom onset, metastatic dissemination at diagnosis, and inherent difficulties of wide surgical resection secondary to the complex and critical anatomy of the pelvis.
Jeffrey Mark Brown, David Matichak, Kyla Rakoczy, John Groundland   +3 more
openaire   +2 more sources

Overall survival, conditioning, and MRD in MORPHO. [PDF]

Blood Adv
Gui G, Hourigan CS.
europepmc   +3 more sources

A novel nomogram to predict the overall survival in esthesinoeroblastoma [PDF]

BMC Cancer, 2020
Abstract Background Increasing evidence indicates that the pathology and the modified Kadish system have some influence on the prognosis of esthesioneuroblastoma (ENB). However, an accurate system to combine pathology with a modified Kadish system has not been established.
Lijie Jiang, Tengjiao Lin, Yu Zhang, Wenxiang Gao, Jie Deng, Zhaofeng Xu, Xin Luo, Zhaoqi Huang, Fenghong Chen, Jianbo Shi, Yinyan Lai   +10 more
openaire   +3 more sources

Presenting features and overall survival of chondrosarcoma of the pelvis

Cancer Treatment and Research Communications, 2022
Chondrosarcoma is the second most common sarcoma of bone. This sarcoma is generally unresponsive to chemotherapy and radiation and is primarily managed through surgical excision. Pelvic chondrosarcoma presents a distinct therapeutic challenge due the complexity of resection, frequent recurrence and metastasis, and high post-operative morbidity.The SEER
Jeffrey Mark Brown, Kyla Rakoczy, Jacqueline Hart, Kevin B Jones, John S Groundland   +4 more
openaire   +3 more sources

Elevated Pulmonary Artery Systolic Pressure is Associated with Poor Survival of Patients with Non-Small Cell Lung Cancer

Cancer Management and Research, 2020
Xue Yang, Lina Wang, Lianjun Lin, Xinmin Liu Department of Geriatrics, Peking University First Hospital, Beijing 100034, People’s Republic of ChinaCorrespondence: Xinmin Liu; Lianjun LinDepartment of Geriatrics, Peking University First Hospital ...
Yang X, Wang L, Lin L, Liu X
doaj  

Prediction of overall survival in patients across solid tumors following atezolizumab treatments: A tumor growth inhibition–overall survival modeling framework

CPT: Pharmacometrics & Systems Pharmacology, 2021
The objectives of the study were to use tumor size data from 10 phase II/III atezolizumab studies across five solid tumor types to estimate tumor growth inhibition (TGI) metrics and assess the impact of TGI metrics and baseline prognostic factors on ...
Phyllis Chan, Mathilde Marchand, Kenta Yoshida, Shweta Vadhavkar, Nina Wang, Alyse Lin, Benjamin Wu, Marcus Ballinger, Nitzan Sternheim, Jin Y. Jin, René Bruno   +10 more
doaj   +1 more source

The Value of lncRNA HULC as a Prognostic Factor for Survival of Cancer Outcome: A Meta-Analysis

Cellular Physiology and Biochemistry, 2017
Aims: Growing evidence from recent studies has shown that lncRNA HULC plays a role in the development of multiple carcinomas. This meta-analysis aimed to analyze available data to identify the prognostic value of HULC in multiple tumors.
Xian Chen, Limin Lun, Huabin Hou, Runhua Tian, Haiping Zhang, Yunyuan Zhang   +5 more
doaj   +1 more source